Vilacto Bio (Vilacto Bio) Short-Term Debt & Capital Lease Obligation : $2.28 Mil (As of Jun. 2019)

View and export this data going back to 2013. Start your Free Trial

What is Vilacto Bio Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Vilacto Bio's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2019 was $2.28 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Vilacto Bio's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2019 was $0.00 Mil.

Vilacto Bio Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Vilacto Bio's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilacto Bio Short-Term Debt & Capital Lease Obligation Chart

Vilacto Bio Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Short-Term Debt & Capital Lease Obligation

Get a 7-Day Free Trial

0.06

0.24

2.48

Vilacto Bio Quarterly Data
	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial															0.33	0.51	2.74	2.48	2.28

Vilacto Bio Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Vilacto Bio Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Vilacto Bio's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Vilacto Bio (Vilacto Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » Short-Term Debt & Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Fabriksvej 48, Suite 2607, The Seagram Building, Naestved, DNK, 4700

Website

https://www.vilacto.com

Vilacto Bio Inc is a biotech company. It operates a fully patented Lactoactive molecule for treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. The company is also intended to develop Lactoactive molecule for increasing the quality of its retail and medical skin cream product as well as developing products for medical applications. Its product portfolio includes lotions, skin care creams and gels, lip balms, foot creams and oils, and others.